BamSEC and AlphaSense Join Forces
Learn More

Scilex Holding Company

NASDAQ: SCLX    
Share price (5/20/25): $5.00    
Market cap (5/20/25): $34.8 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 2 pages Scilex Holding Company (The “Company”) Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.78
from POS AM 11 pages April 16, 2025 Scilex Holding Company 960 San Antonio Rd. Palo Alto, Ca 94303 Attn: Stephen Ma via Email Re: Consent, Waiver and Amendment Re Tranche B Senior Secured Convertible Note and Related Transaction Documents (This “Consent, Waiver and Amendment”) Ladies and Gentlemen
12/34/56
EX-10.77
from POS AM 11 pages April 16, 2025 Scilex Holding Company 960 San Antonio Rd. Palo Alto, Ca 94303 Attn: Stephen Ma via Email Re: Consent, Waiver and Amendment Re Tranche B Senior Secured Convertible Note and Related Transaction Documents (This “Consent, Waiver and Amendment”) Ladies and Gentlemen
12/34/56
EX-10.76
from POS AM 12 pages April 16, 2025 Scilex Holding Company 960 San Antonio Rd. Palo Alto, Ca 94303 Attn: Stephen Ma via Email Re: Consent, Waiver and Amendment Re Tranche B Senior Secured Convertible Note and Related Transaction Documents (This “Consent, Waiver and Amendment”) Ladies and Gentlemen
12/34/56
EX-10.75
from POS AM 11 pages April 16, 2025 Scilex Holding Company 960 San Antonio Rd. Palo Alto, Ca 94303 Attn: Stephen Ma via Email Re: Consent, Waiver and Amendment Re Tranche a Senior Secured Promissory Note and Related Transaction Documents (This “Consent, Waiver and Amendment”) Ladies and Gentlemen
12/34/56
EX-10.37
from 10-K 9 pages First Amendment to License and Commercialization Agreement
12/34/56
EX-10.33
from 10-K 9 pages *** Certain Identified Information Has Been Omitted From This Exhibit Because It Is Both (I) Not Material and (II) Information That the Registrant Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[...***...]”) in This Exhibit. *** Second Amendment to Master Services Agreement
12/34/56
EX-10.5
from 8-K 42 pages Gloperba License Agreement Dated as of February 28, 2025 by and Between Scilex Holding Company, Scilex Pharmaceuticals Inc., as the Licensor Parties and Royaltyvest Ltd. as Licensee
12/34/56
EX-10.4
from 8-K 7 pages Amendment No. 1 to Purchase and Sale Agreement
12/34/56
EX-10.3
from 8-K 15 pages Subordination Agreement
12/34/56
EX-10.2
from 8-K 16 pages Security Agreement
12/34/56
EX-10.1
from 8-K 49 pages Purchase and Sale Agreement Dated as of February 28, 2025 by and Among Scilex Holding Company, Scilex Pharmaceuticals Inc., as the Seller Parties and Efshar Hataya Ltd, Oramed Pharmaceuticals Inc., and 3i, LP as the Purchasers
12/34/56
EX-10.2
from 8-K 7 pages February 22, 2025 Scilex Holding Company 960 San Antonio Road Palo Alto, Ca 94303 Attn: Stephen Ma via Email Re: Parent Guarantee for Lidocaine License Agreement (This “Side Letter”) Ladies and Gentlemen
12/34/56
EX-10.1
from 8-K 42 pages Lidocaine License Agreement Dated as of February 22, 2025 by and Between Scilex Pharmaceuticals Inc. as Licensor and Royaltyvest Ltd. as Licensee
12/34/56
EX-10.1
from 8-K 6 pages January 21, 2025 SCLX Stock Acquisition Jv 960 San Antonio Rd. Palo Alto, Ca 94303 Attn: Xiao Xu and Scilex Holding Company 960 San Antonio Rd. Palo Alto, Ca 94303 Attn: Stephen Ma via Email Re: Amendment to Senior Secured Promissory Note (This “Amendment”) Ladies and Gentlemen
12/34/56
EX-10.5
from SCHEDULE 13D/A Material contract
12/34/56
EX-10.4
from SCHEDULE 13D/A Material contract
12/34/56
EX-10.3
from SCHEDULE 13D/A Material contract
12/34/56
EX-10.2
from SCHEDULE 13D/A Material contract
12/34/56
EX-10.1
from SCHEDULE 13D/A Material contract
12/34/56